Midkine: A Novel Biomarker to Predict Malignancy in Patients with Nodular Thyroid Disease

Background. Midkine (MK), a new heparin-binding growth factor, plays important roles in a variety of biological phenomena such as carcinogenesis, inflammation, and angiogenesis. In this study, we aimed to evaluate serum midkine (SMK) and nodular midkine (NMK) levels in patients with thyroid nodules...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Endocrinol
Autors principals: Kuzu, Fatih, Arpaci, Dilek, Unal, Mustafa, Altas, Ayfer, Haytaoglu, Gürkan, Can, Murat, Barut, Figen, Kokturk, Furuzan, Ilikhan, Sevil Uygun, Bayraktaroglu, Taner
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4944023/
https://ncbi.nlm.nih.gov/pubmed/27446208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6035024
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars